Showing results (1201-1210 of 1,341) with videos related to

Sort By:
Pageof 135
Medicina Clinica|February 20, 2002
[Locoregional recurrences after conservative treatment of breast cancer stage I-II]M José Fuentes Raspall, Encarna Piedrafita Serra, José Isern Verdum, et al.
AIDS (London, England)|September 28, 2021
Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressorsVinicius A Vieira, Jane Millar, Emily Adland, et al.
Medicina Clinica|November 23, 1996
[Retrospective multicenter study of the efficacy of interferon alpha in chronic hepatitis C]J Salmerón, R Martín-Vivaldi, A Palacios, et al.
Frontiers in Pharmacology|August 23, 2024
Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case studyJuan Granja López, Carlos Estebas Armas, Manuel Lorenzo Dieguez, et al.
AIDS (London, England)|March 27, 2026
Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruptionGabriela Zl Cromhout, Nomonde Bengu, Nicholas G Herbert, et al.
Plos One|September 28, 2017
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-BMiriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, et al.
International Archives of Medicine|February 17, 2012
Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-αEduardo Puertas-Abreu, Elaudi Rodríguez Polanco, Miriam Azocar, et al.
Antioxidants (Basel, Switzerland)|September 27, 2025
Dysregulated Expression of Canonical and Non-Canonical Glycolytic Enzyme Isoforms in Peripheral Blood from Subjects with Alcohol Use Disorder and from Individuals with Acute Alcohol ConsumptionMaura Rojas-Pirela, Daniel Salete-Granado, Diego Andrade-Alviárez, et al.
Science Immunology|November 19, 2021
Protection against autoimmunity is driven by thymic epithelial cell-mediated regulation of T<sub>reg</sub> developmentClaudia Haftmann, Pascale Zwicky, Florian Ingelfinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processingSonia Melo, Alberto Villanueva, Catia Moutinho, et al.
Pageof 135